Status:
COMPLETED
Coronary Arteriogenetic Heparinized Exercise
Lead Sponsor:
Clinical Centre of Serbia
Collaborating Sponsors:
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
Conditions:
Refractory Angina
Chronic Stable Angina
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study evaluates the addition of heparin to a 2-week cycle of physical rehabilitation in the treatment of refractory angina. Half of the patients will undergo heparin-primed physical rehabilitatio...
Detailed Description
Our approach is based on the combination of pharmacological stimuli (with heparin) on top of a 2-week cycle of physical rehabilitation. The rationale for this chemical-physical cocktail stems from the...
Eligibility Criteria
Inclusion
- Patients with documented coronary artery disease not amenable of future treatment and belonging to "no-option" category with symptoms consistent with angina pectoris
Exclusion
- Patients with unstable angina, recent myocardial infarction, uncontrolled hypertension, hemodynamically valvular heart disease, bronchial asthma, and neurologic and/or orthopedic illnesses that limit exercise capacity .
- Patients receiving vitamin K antagonist.
- Patients actively involved in programmes of cardiac rehabilitation or exercise training.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03350737
Start Date
February 1 2013
End Date
December 31 2019
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Centre of Serbia
Belgrade, Serbia, 11000